Cargando…

Understanding the Importance of Capsules in Dry Powder Inhalers

Pulmonary drug delivery is currently the focus of research and development because of its potential to produce maximum therapeutic benefit to patients by directing the drug straight to the lung disease site. Among all the available delivery options, one popular, proven and convenient inhaler device...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buttini, Francesca, Quarta, Eride, Allegrini, Chiara, Lavorini, Federico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623721/ https://www.ncbi.nlm.nih.gov/pubmed/34834351 http://dx.doi.org/10.3390/pharmaceutics13111936

Ejemplares similares

Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

Erratum to: Recent advances in capsule-based dry powder inhaler technology
por: Lavorini, Federico, et al.
Publicado: (2017)

Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes
por: Levy, Mark L., et al.
Publicado: (2019)

RespiCell(TM): An Innovative Dissolution Apparatus for Inhaled Products
por: Sonvico, Fabio, et al.
Publicado: (2021)

A Quality by Design Framework for Capsule-Based Dry Powder Inhalers
por: Ding, Li, et al.
Publicado: (2021)

An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro
por: D’Angelo, Davide, et al.
Publicado: (2023)

Switching to the Dry-Powder Inhaler Easyhaler(®): A Narrative Review of the Evidence
por: Lavorini, Federico, et al.
Publicado: (2021)

Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler
por: Buttini, Francesca, et al.
Publicado: (2015)

Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers
por: Buttini, Francesca, et al.
Publicado: (2016)

Recent Patents on Nasal Vaccines Containing Nanoadjuvants
por: Candela, Francesco, et al.
Publicado: (2022)

Inhalable Microparticles Embedding Biocompatible Magnetic Iron-Doped Hydroxyapatite Nanoparticles
por: Quarta, Eride, et al.
Publicado: (2023)

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization
por: Groß, Roman, et al.
Publicado: (2022)

Ease-of-use preference for the ELLIPTA(®) dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older
por: Komase, Yuko, et al.
Publicado: (2014)

Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis
por: Han, Xiaoxuan, et al.
Publicado: (2023)

An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
por: Marante, Tânia, et al.
Publicado: (2020)

Feedback systems in multi-dose dry powder inhalers
por: Emeryk, Andrzej, et al.
Publicado: (2022)

Influence of physical properties of carrier on the performance of dry powder inhalers
por: Peng, Tingting, et al.
Publicado: (2016)

Clinical recommendations for dry powder inhaler use in the management of COPD in primary care
por: Leving, Marika T., et al.
Publicado: (2022)

Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
por: Quarta, Eride, et al.
Publicado: (2021)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Understanding Carrier Performance in Low-Dose Dry Powder Inhalation: An In Vitro–In Silico Approach
por: Pinto, Joana T., et al.
Publicado: (2021)

Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering
por: Mehta, Piyush
Publicado: (2018)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives
por: Xiroudaki, Styliani, et al.
Publicado: (2021)

Dry powder inhalers and the right things to remember: a concept review
por: Dal Negro, Roberto W
Publicado: (2015)

Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
por: Pardeshi, Sagar R., et al.
Publicado: (2022)

Effect of Inhaler Design Variables on Paediatric Use of Dry Powder Inhalers
por: Lexmond, Anne J., et al.
Publicado: (2014)

Performance of Dry Powder Inhalers with Single Dosed Capsules in Preschool Children and Adults Using Improved Upper Airway Models
por: Lindert, Sandra, et al.
Publicado: (2014)

Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder
por: Saha, Tushar, et al.
Publicado: (2022)

Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study
por: Chrystyn, Henry, et al.
Publicado: (2016)

Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler
por: Son, Yoen-Ju, et al.
Publicado: (2021)

Usability and Robustness of the Wixela Inhub Dry Powder Inhaler
por: Allan, Richard, et al.
Publicado: (2021)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics
por: Abiona, Olaitan, et al.
Publicado: (2022)

Advancements in the Design and Development of Dry Powder Inhalers and Potential Implications for Generic Development
por: Mohan, Abhinav Ram, et al.
Publicado: (2022)

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis
por: Uttley, Lesley, et al.
Publicado: (2013)

Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
por: Knap, Karolina, et al.
Publicado: (2022)

Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers
por: W. H. Kocks, Janwillem, et al.
Publicado: (2022)

Nanospray Drying as a Novel Technique for the Manufacturing of Inhalable NSAID Powders
por: Rita Patrizia, Aquino, et al.
Publicado: (2014)

Effect of compression pressure on inhalation grade lactose as carrier for dry powder inhalations
por: Raut, Neha Sureshrao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_72tjfe14b9ob92pehvfj07rk6g